Patents by Inventor Jan Öhrström

Jan Öhrström has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7842292
    Abstract: The present invention provides methods and compositions for treatment of B-cell malignancies, including non-Hodgkin's lymphoma, comprising administering to a patient in need of the treatment a TACI-Ig fusion molecule in amount sufficient to suppress proliferation-inducing functions of BlyS and APRIL.
    Type: Grant
    Filed: August 9, 2006
    Date of Patent: November 30, 2010
    Assignees: Ares Trading S.A., Zymogenetics, Inc., Mayo Foundation for Medical Education and Research
    Inventors: Herve Broly, Arnaud Ythier, Eric Sievers, Sharon J. Busby, Jan Öhrström, Ivan Nestorov, Stephen M. Ansell
  • Publication number: 20090264347
    Abstract: A patient having hemophilia A is treated by administering factor XIII generally in conjunction with factor VIII or desmopressin.
    Type: Application
    Filed: June 30, 2009
    Publication date: October 22, 2009
    Applicant: ZymoGenetics Inc.
    Inventors: Jan Ohrstrom, Paul D. Bishop, Lynn Massman Rose
  • Publication number: 20090036361
    Abstract: A patient having hemophilia A is treated by administering factor XIII generally in conjunction with factor VIII or desmopressin.
    Type: Application
    Filed: October 2, 2008
    Publication date: February 5, 2009
    Applicant: ZymoGenetics Inc.
    Inventors: Jan Ohrstrom, Paul D. Bishop, Lynn Massman Rose
  • Patent number: 7429566
    Abstract: Use of factor XIII for treating hemophilia B. A patient having hemophilia B is treated by administering factor XIII, generally in conjunction with factor IX.
    Type: Grant
    Filed: September 15, 2006
    Date of Patent: September 30, 2008
    Assignee: Zymogenetics Inc.
    Inventors: Jan Öhrström, Lynn Massman Rose, Paul D. Bishop
  • Publication number: 20070122384
    Abstract: A method for treating inflammatory bowel disease by administering interferon beta in conjunction with factor XIII to a mammal afflicted with the disease. The IBD may either be ulcerative colitis or Crohn's disease. The factor XIII used may be recombinant or nonrecombinant. The interferon beta used can be naturally occurring interferon beta, interferon beta-1a or interferon beta-1b.
    Type: Application
    Filed: December 19, 2006
    Publication date: May 31, 2007
    Applicant: ZYMOGENETICS, INC.
    Inventor: Jan Ohrstrom
  • Publication number: 20070071760
    Abstract: The present invention provides methods and compositions for treatment of B-cell malignancies, including non-Hodgkin's lymphoma, comprising administering to a patient in need of the treatment a TACI-Ig fusion molecule in amount sufficient to suppress proliferation-inducing functions of BlyS and APRIL.
    Type: Application
    Filed: August 9, 2006
    Publication date: March 29, 2007
    Inventors: Herve Broly, Arnaud Ythier, Eric Sievers, Sharon Busby, Jan Ohrstrom, Ivan Nestorov, Stephen Ansell
  • Publication number: 20070021340
    Abstract: A patient having hemophilia A is treated by administering factor XIII generally in conjunction with factor VIII or desmopressin.
    Type: Application
    Filed: September 20, 2006
    Publication date: January 25, 2007
    Applicant: ZymoGenetics Inc.
    Inventors: Jan Ohrstrom, Paul Bishop, Lynn Rose
  • Publication number: 20070015709
    Abstract: Use of factor XIII for treating hemophilia B. A patient having hemophilia B is treated by administering factor XIII, generally in conjunction with factor IX.
    Type: Application
    Filed: September 15, 2006
    Publication date: January 18, 2007
    Applicant: ZymoGenetics Inc.
    Inventors: Jan Ohrstrom, Lynn Rose, Paul Bishop
  • Publication number: 20060104946
    Abstract: A method for treating inflammatory bowel disease by administering interferon beta in conjunction with factor XIII to a mammal afflicted with the disease. The IBD may either be ulcerative colitis or Crohn's disease. The factor XIII used may be recombinant or nonrecombinant. The interferon beta used can be naturally occurring interferon beta, interferon beta-1a or interferon beta-1b.
    Type: Application
    Filed: August 25, 2003
    Publication date: May 18, 2006
    Applicant: ZYMOGENETICS, INC.
    Inventor: Jan Ohrstrom
  • Publication number: 20040033947
    Abstract: Use of factor XIII for treating hemophilia B. A patient having hemophilia B is treated by administering factor XIII generally in conjunction with factor IX.
    Type: Application
    Filed: May 7, 2003
    Publication date: February 19, 2004
    Inventors: Jan Ohrstrom, Lynn M. Rose, Paul D. Bishop
  • Publication number: 20040014657
    Abstract: Use of factor XIII for treating hemophilia A. A patient having hemophilia A is treated by administering factor XIII generally in conjunction with factor VIII or desmopressin.
    Type: Application
    Filed: April 29, 2003
    Publication date: January 22, 2004
    Inventors: Jan Ohrstrom, Paul D Bishop, Lynn Massman Rose